ArticleJournal of cancer research and clinical oncology2018

Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial-mesenchymal transition phenotype.

Jing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.